Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models



Rating:

Share or cite this content

Citations should be made in the following way:
H. Rouhi Boroujeni, B. Pourgheysari, A. Hasheminia (Shahrekord, Islamic Republic Of Iran). PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events. Eur Respir J 2012; 40: Suppl. 56, 955

Member's Comments

No comment yet.

Related content which might interest you: Risk of venous thromboembolism (VTE) in first degree relatives (FDRS) of patients with unprovoked VTE who do not have factor V Leiden (FVL) or the G20210A prothrombin gene mutation (PGM) Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis Source: Eur Respir J 2003; 21: 25-30 Year: 2003 The G20210A polymorphism of the prothrombin gene is the strong genetic risk factor for the pulmonary embolism development in young patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 Platelet glycoprotein Ia 807C/T and 873G/A dimorphisms in patients with venous thromboembolism Source: Eur Respir J 2004; 24: Suppl. 48, 275s Year: 2004 Prothrombin 20210 G/A mutation and EPCR I/D polymorphisms were rare in patients with pulmonary thromboembolism in Chinese Han population Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Massive pulmonary embolism as the first manifestation in a patient with double heterozygocity for MTHFR and prothrombin 20210 G/A Source: Eur Respir J 2003; 22: Suppl. 45, 443s Year: 2003 The impact of screening for factor V Leiden (FVL) first degree relatives of patients with venous thromboembolism (VTE) and FVL on their risk of VTE Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Factors that predict the risk of recurrent venous thromboembolism (VTE) in patients with VTE and factor V Leiden (FVL) Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 56 (4) 2000774; 10.1183/13993003.00774-2020 Year: 2020 Prothrombin gene variant (20210A) as cause of thromboembolic events in a young pregnant woman Source: Eur Respir J 2001; 18: Suppl. 33, 382s Year: 2001 The role of thrombophilic risk factors in the severity of pulmonary thromboembolism Source: Eur Respir J 2002; 19: 709-711 Year: 2002 Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2008; 31: 736-741 Year: 2008 The relation between the tissue-plasminogen activator gene polymorphism and venous thromboembolism Source: Annual Congress 2004 - Pulmonary embolism Year: 2004 D-dimer in patients with venous thromboembolism who carry hereditary thrombophilia Source: Eur Respir J 2006; 28: Suppl. 50, 46s Year: 2006 Anti-Factor Xa levels correlate with recurrent venous thromboembolism and clinically relevant bleeding in patients receiving low-molecular-weight heparin. Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 Factor V Leiden mutation does not affect coagulopathy or outcome in lethal H1N1 influenza Source: Eur Respir J 2010; 36: 1346-1354 Year: 2010 Inherited thrombophilic risk factors in venous thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 239s Year: 2002 Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion. Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Microalbuminuria and von Willebrand factor antigen (vWF) as markers of endothelial dysfunction in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 123s Year: 2004 Age is a major risk factor of venous thromboembolism (VTE) Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011